NDC Package 55621-005-01 Theraplus Plus

Phenylephrine Hci Ointment Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55621-005-01
Package Description:
42 g in 1 TUBE
Product Code:
Proprietary Name:
Theraplus Plus
Non-Proprietary Name:
Phenylephrine Hci
Substance Name:
Mineral Oil; Petrolatum; Phenylephrine Hydrochloride
Usage Information:
Uses-helps relieve the local itching and discomfort associated with hemorrhoids-temporarily shrinks hemorrhoid tissue and relieves burning-temporarily provides a coating for relief of anorectal discomforts-temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful
11-Digit NDC Billing Format:
55621000501
NDC to RxNorm Crosswalk:
  • RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment
  • RxCUI: 1372298 - mineral oil 0.14 MG/MG / petrolatum 0.749 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
  • RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment
  • Product Type:
    Human Otc Drug
    Labeler Name:
    Zhejiang Jingwei Pharmaceutical Co., Ltd.
    Dosage Form:
    Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    M015
    Marketing Category:
    OTC MONOGRAPH DRUG -
    Start Marketing Date:
    03-01-2013
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 55621-005-01?

    The NDC Packaged Code 55621-005-01 is assigned to a package of 42 g in 1 tube of Theraplus Plus, a human over the counter drug labeled by Zhejiang Jingwei Pharmaceutical Co., Ltd.. The product's dosage form is ointment and is administered via topical form.

    Is NDC 55621-005 included in the NDC Directory?

    Yes, Theraplus Plus with product code 55621-005 is active and included in the NDC Directory. The product was first marketed by Zhejiang Jingwei Pharmaceutical Co., Ltd. on March 01, 2013 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 55621-005-01?

    The 11-digit format is 55621000501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-255621-005-015-4-255621-0005-01